Eli Lilly (LLY) Total Current Liabilities (2009 - 2026)

Eli Lilly (LLY) has 18 years of Total Current Liabilities data on file, last reported at $36.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 21.84% year-over-year to $36.6 billion; the trailing twelve-month figure through Mar 2026 stood at $36.6 billion (up 21.84% YoY), and the FY2025 full-year result was $35.2 billion, up 24.15% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $36.6 billion, up from $35.2 billion in the prior quarter.
• Across five years, Total Current Liabilities topped out at $40.1 billion in Q3 2025 and bottomed at $13.4 billion in Q1 2022.
• The 5-year median for Total Current Liabilities is $24.7 billion (2024), against an average of $25.1 billion.
• The widest annual swing landed in 2022, when Total Current Liabilities grew 3.49%; it then jumped 62.68% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $17.1 billion in 2022, then surged by 59.25% to $27.3 billion in 2023, then grew by 3.97% to $28.4 billion in 2024, then grew by 24.15% to $35.2 billion in 2025, then gained by 3.99% to $36.6 billion in 2026.
• The last three Total Current Liabilities figures came in at $36.6 billion (Q1 2026), $35.2 billion (Q4 2025), and $40.1 billion (Q3 2025), per Business Quant data.

Peer Comparison